On September 28, the MCB community hosted representatives from nine major Bay Area biotechnology companies for the second annual Fall 2018 Industrial Affiliates Program (IAP) Symposium. The event was a great success, drawing approximately 100 students and postdoctoral scholars from several departments on campus including MCB, Bioengineering, Biostatistics, Biophysics, and Chemistry.
Below are articles from various sources about members of MCB and their research.
MCB Assistant Adjunct Professor Denis Titov is a 2018 recipient of the NIH Director's New Innovator award, which funds high-impact research from "extraordinarily creative scientists." The New Innovator award specifically supports early career researchers carrying out highly innovative biomedical research.
Titov joined the MCB Department in 2018. His research focuses on aging and age-associated diseases.
Immunologist James P. Allison shares the 2018 Nobel Prize in Physiology or Medicine with Tasuku Honjo of Kyoto University “for their discovery of cancer therapy by inhibition of negative immune regulation.”
Allison performed the basic research that revolutionized immunotherapy for use in treating cancer at UC Berkeley, where he was a Professor of Immunology and the director of the Cancer Research Laboratory from 1985 to 2004.
"This award is a testament to the incredible impact that the fundamental research Jim conducted at Berkeley has had on the lives of cancer patients," said MCB Professor Russell Vance, current director of the Cancer Research Laboratory.
The University of California, Berkeley seeks applications for up to five tenure-track positions in the Life Sciences with a potential start date of July 1, 2019.
MCB is delighted to join faculty from UCSF, Stanford, and other UC Berkeley departments in cutting-edge biomedical research funded by the Chan Zuckerberg Biohub Intercampus Research Awards! The Biohub will provide $13.7 million toward several collaborative research projects in labs around the Bay Area.
In a NeuroView article in the journal Neuron, MCB Professor Marla Feller discusses the challenges experienced and invaluable rewards gained when researchers commit to instructing undergraduate students.
"Teaching undergraduates is part of the academic commitment for many neuroscience faculty. While some scientists view this as a major distraction from research, teaching is of high value, both in training young scientists and for informing one’s own scientific investigations."
A new paper from the lab of MCB Professors Georjana Barnes and David Drubin details the use of a cell-free assay in budding yeast lysates to reconstitute microtubule regulation.
The research demonstrates that the cell division cycle and the activities of specific MAPs (microtubule-associated proteins) affect both microtubule polymerization and dynamic instability (the stochastic growth and shrinkage of microtubules that are necessary for cell functioning and division).
We had a fantastic weekend in Asilomar, CA, for our annual MCB Cell & Developmental Biology retreat. Thank you to David Drubin and Matt Welch for the photos, and to Diana Bautista and David Bilder for organizing such a successful event!
Congratulations to the 2018 class of HHMI Hanna Gray Fellows, including MCB PhD alums Carolyn Elya, Jeannette Tenthorey, and Arielle Woznica, as well as current MCB Postdoc Sara Campbell!
The Hanna Gray Fellowship is designed to support exceptional early career researchers from a diverse set of backgrounds. Fellows receive mentorship from the HHMI community and research funding for 8 years throughout their postdoctoral research and into a tenure-track faculty position.
MCB & Chemistry Professor and HHMI Investigator Jennifer Doudna has been awarded the 2018 Pearl Meister Greengard Prize by The Rockefeller University. The prize honors women in biology who have made outstanding and revolutionary contributions to their field. Congratulations, Professor Doudna!
A groundbreaking new study from the labs of MCB Professors Michael Rape and Richard Harland describes a quality control pathway, called DQC (dimerization quality control), for regulators of the BTB family. DQC removes BTB dimers of abberant composition from interrupting signal transduction in a cell.
A team of researchers led by MCB Professor Daniel Portnoy has discovered that many bacteria in the human gut microbiome, such as the species which cause listeriosis and gangrene, produce electricity as part of their metabolic processes.
MCB Professor David Raulet, Univ. of Ottawa & Ottawa Hospital's Michele Ardolino and their colleagues' paper in The Journal of Clinical Investigation describes the important role Natural Killer (NK) cells may play in targeting tumors when combined with cancer immunotherapy drugs called checkpoint inhibitors.
They are currently investigating approaches to further enhance the cancer-killing ability of NK cells, and hope to someday profile how an individual's immune system interacts with their cancer, enabling more personalized immunotherapy treatments.
Congratulations to MCB Professor Matt Welch, who was recently named one of 13 new ASCB Fellows! This fellowship recognizes those in the field of cell biology who have exhibited a career-long commitment to the mission of the ASCB.
Professor Welch and the twelve other new Fellows will be recognized at the ASCB|EMBO Meeting in December 2018 in San Diego.
MCB Assistant Professor Eunyoung Park was named a 2018 Vallee Scholar by the Vallee Foundation, which awards $300,000 research grants to exceptional early career researchers and investigators. Assistant Professor Park's research focuses on the molecular mechanisms of protein translocation across cell membranes.